Literature DB >> 7754748

Parkinsonism in motor neuron disease: case report and literature review.

T L Williams1, P J Shaw, J Lowe, D Bates, P G Ince.   

Abstract

This report describes a patient who had clinical features of both motor neuron disease and Parkinson's disease. Neuropathological examination and immunocytochemical studies showed that he had motor neuron disease of the progressive muscular atrophy type, and Lewy body Parkinson's disease, with intracytoplasmic inclusion bodies characteristic of both conditions. This is the first detailed description of these two diseases occurring concurrently in the same patient. A review of all previously reported cases of combined motor neuron disease and parkinsonism has led to the following conclusions: (1) that these two neuropathologically defined diseases occur together very infrequently, but (2) that parkinsonism and substantia nigra degeneration are not uncommon as part of the multi-system disease process underlying motor neuron disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7754748     DOI: 10.1007/BF00309344

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  55 in total

1.  Alzheimer's neurofibrillary changes. A topographic study.

Authors:  A HIRANO; H M ZIMMERMAN
Journal:  Arch Neurol       Date:  1962-09

2.  Cognitive impairment in amyotrophic lateral sclerosis and its relation to motor disabilities.

Authors:  Y Iwasaki; M Kinoshita; K Ikeda; K Takamiya; T Shiojima
Journal:  Acta Neurol Scand       Date:  1990-02       Impact factor: 3.209

3.  Sporadic and familial parkinsonism and motor neuron disease.

Authors:  K Brait; S Fahn; G A Schwarz
Journal:  Neurology       Date:  1973-09       Impact factor: 9.910

4.  [Clinical and pathological findings in the syndrome amyotrophy-parkinsonism-dementia (author's transl)].

Authors:  H Kaiya; P Mehraein
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1974-06-08

5.  [Case of atypical Pick's disease].

Authors:  Y Tsujiyama; M Shigeta; M Kudo; M Takayama
Journal:  No To Shinkei       Date:  1967-09

6.  The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis. A neuropsychological and positron emission tomography study.

Authors:  J J Kew; L H Goldstein; P N Leigh; S Abrahams; N Cosgrave; R E Passingham; R S Frackowiak; D J Brooks
Journal:  Brain       Date:  1993-12       Impact factor: 13.501

7.  Hereditary Amyotrophic Lateral Sclerosis. A report of two families.

Authors:  M Alter; B Schaumann
Journal:  Eur Neurol       Date:  1976       Impact factor: 1.710

8.  Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning.

Authors:  H Takahashi; B J Snow; M H Bhatt; R Peppard; A Eisen; D B Calne
Journal:  Lancet       Date:  1993-10-23       Impact factor: 79.321

9.  Motor neuron disease with pallido-luysio-nigral atrophy.

Authors:  M Bergmann; K Kuchelmeister; A Migheli; D Schiffer; F Gullotta
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Cognitive impairment in motor neuron disease.

Authors:  R Gallassi; P Montagna; C Ciardulli; S Lorusso; V Mussuto; A Stracciari
Journal:  Acta Neurol Scand       Date:  1985-06       Impact factor: 3.209

View more
  4 in total

1.  Clinical and neuroimaging characteristics in neurodegenerative overlap syndrome.

Authors:  Young-Min Lim; Hee Kyung Park; Jae Seung Kim; Chong Sik Lee; Sun Ju Chung; Jimin Kim; Kwang-Kuk Kim
Journal:  Neurol Sci       Date:  2012-06-28       Impact factor: 3.307

2.  The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats.

Authors:  S Samantaray; V H Knaryan; M K Guyton; D D Matzelle; S K Ray; N L Banik
Journal:  Neuroscience       Date:  2007-03-23       Impact factor: 3.590

3.  Beta-band intermuscular coherence: a novel biomarker of upper motor neuron dysfunction in motor neuron disease.

Authors:  Karen M Fisher; Boubker Zaaimi; Timothy L Williams; Stuart N Baker; Mark R Baker
Journal:  Brain       Date:  2012-06-22       Impact factor: 13.501

4.  C9ORF72 intermediate repeat copies are a significant risk factor for Parkinson disease.

Authors:  Karen Nuytemans; Güney Bademci; Martin M Kohli; Gary W Beecham; Liyong Wang; Juan I Young; Fatta Nahab; Eden R Martin; John R Gilbert; Michael Benatar; Jonathan L Haines; William K Scott; Stephan Züchner; Margaret A Pericak-Vance; Jeffery M Vance
Journal:  Ann Hum Genet       Date:  2013-07-12       Impact factor: 1.670

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.